Tokyo Tape
Sign in
← Santen Pharmaceutical

Quarterly report · Q2

4536.TEDINET S100PIVT
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥128.9bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥63.4bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥266.3bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥128.8bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥63.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income−¥19.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income−¥27.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥18.8bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥9.7bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax−¥19.1bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥28.2bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥35.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥18.4bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥9.2bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥27.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥14.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.0bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥22.0bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income−¥28.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥14.3bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥6.9bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥426.6bnat 2022-09-30Cons.Assets IFRS
Total assets¥460.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥420.4bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥117.2bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥123.1bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥309.4bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥336.8bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥319.0bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥309.6bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥310.1bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥337.5bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥319.6bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥69.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥83.0bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥76.0bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥62.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥18.3bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥46.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥27.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥18.8bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥35.2bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥17.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥16.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥5.6bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥3.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-56.052022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-75.562022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥68.072021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥35.792021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.432021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-56.052022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-75.562022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.972021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥35.732021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.392021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio72.7%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio73.4%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio76.0%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 655
ItemContextValueUnit
Share based payment transactions ss IFRSCurrentYTDDuration65000000JPY
Other ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-519000000JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Other ss IFRSCurrentYTDDuration－JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareAcquisitionRightsIFRSMember-5000000JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-523000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-19017000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration-19017000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember30037000000JPY
Equity IFRSCurrentQuarterInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember2378000000JPY
Equity IFRSCurrentQuarterInstant_ShareAcquisitionRightsIFRSMember380000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember42807000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember310072000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember-657000000JPY
Equity IFRSCurrentQuarterInstant309415000000JPY
Profit loss IFRSPrior1YTDDuration14254000000JPY
Profit loss IFRSCurrentYTDDuration-22019000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration8302000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration9020000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration48000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration30501000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration643000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration1064000000JPY
Finance income and finance costs ope cf IFRSPrior1YTDDuration-343000000JPY
Finance income and finance costs ope cf IFRSCurrentYTDDuration-227000000JPY
Income tax expense ope cf IFRSPrior1YTDDuration4139000000JPY
Income tax expense ope cf IFRSCurrentYTDDuration2917000000JPY
Decrease increase in trade and other receivables ope cf IFRSPrior1YTDDuration9885000000JPY
Decrease increase in trade and other receivables ope cf IFRSCurrentYTDDuration13827000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration1468000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-1263000000JPY
Increase decrease in trade and other payables ope cf IFRSPrior1YTDDuration-338000000JPY
Increase decrease in trade and other payables ope cf IFRSCurrentYTDDuration-4430000000JPY
Increase decrease in provisions and net defined benefit liabilities ope cf IFRSPrior1YTDDuration378000000JPY
Increase decrease in provisions and net defined benefit liabilities ope cf IFRSCurrentYTDDuration-7000000JPY
Increase decrease in other current liabilities ope cf IFRSPrior1YTDDuration-2705000000JPY
Increase decrease in other current liabilities ope cf IFRSCurrentYTDDuration-1241000000JPY
Increase decrease in accounts payable bonuses ope cf IFRSPrior1YTDDuration-1516000000JPY
Increase decrease in accounts payable bonuses ope cf IFRSCurrentYTDDuration-3765000000JPY
Increase decrease in accounts payable other ope cf IFRSPrior1YTDDuration-1381000000JPY
Increase decrease in accounts payable other ope cf IFRSCurrentYTDDuration-2434000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration-1058000000JPY
Other changes in working capital ope cf IFRSCurrentYTDDuration-110000000JPY
Subtotal ope cf IFRSPrior1YTDDuration31777000000JPY
Subtotal ope cf IFRSCurrentYTDDuration21831000000JPY
Interest received ope cf IFRSPrior1YTDDuration136000000JPY
Interest received ope cf IFRSCurrentYTDDuration113000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass